Regulations/Legal

Latest Issue of OR Manager
January 2025
Home Regulations/Legal

CDC health advisory update on treating COVID-19 recurrence with antiviral pill

Editor's Note The Centers for Disease Control and Prevention (CDC) on May 24 issued a Health Alert Network Health Advisory to update healthcare providers and the public on treating the potential for recurrence of COVID-19, also termed “COVID-19 rebound.” According to the health advisory update, there is “currently no evidence…

Read More

By: Tarsilla Moura
May 25, 2022
Share

FDA: Class I recall of Woodside Acquisitions SARS-CoV-2 antigen rapid test kits

Editor's Note The Food and Drug Administration (FDA) on May 16 identified the recall of Woodside Acquisitions Inc’s Oral Rapid SARS-CoV-2 Antigen Rapid Test Kits and Joysbio SARS-CoV-2 Antigen Rapid Test Kits (Colloidal Gold) as Class I, the most serious. The tests are being recalled because they were distributed to…

Read More

By: Judy Mathias
May 24, 2022
Share

Association of COVID-19 with disparities in access to major surgery

Editor's Note This study, led by researchers from the University of Rochester (NY) School of Medicine, finds that the early response to the COVID-19 pandemic did not increase disparities in access to major surgical procedures. Of 3,470,905 adults hospitalized for major surgical procedures at 719 facilities between January 1, 2018,…

Read More

By: Judy Mathias
May 23, 2022
Share

ACS: Prevent BLEEDing Act introduced in Congress

Editor's Note The American College of Surgeons (ACS), on May 19, announced that it strongly supports legislation that creates a grant program to provide training on bleeding control techniques and anti-blood loss supplies for use in medical emergencies. The “Prevent Blood Loss with Emergency Equipment Devices Act (Prevent Bleeding Act),”…

Read More

By: Judy Mathias
May 23, 2022
Share

Sponsored Message

Increasing face-mask compliance among HCWs during COVID-19

Editor's Note In this study, researchers from Yale School of Medicine, New Haven, Connecticut, find that face-mask compliance remained suboptimal among healthcare workers (HCWs) despite a facility-wide mandate for universal masking during the COVID-19 pandemic. Of 1,561 observations during a 4-week baseline period after universal masking was mandated, median weekly…

Read More

By: Judy Mathias
May 19, 2022
Share

ECRI: Time to move to scheduled COVID-19 vaccinations

Editor's Note In a May 18 position statement, ECRI recommends that it’s time to move to a regularly scheduled COVID-19 vaccine booster model. “Moving to a regular vaccine schedule will increase clarity and confidence about what actions to take and when, compared to the current piecemeal, wait-and-see approach,” says Marcus…

Read More

By: Judy Mathias
May 19, 2022
Share

Sponsored Message

The Joint Commission posts reminder to submit applications for Bernard J. Tyson Award

Editor's Note The Joint Commission, on May 18, posted a reminder for organizations to submit applications for the Bernard J. Tyson National Award for Excellence in Pursuit of Health Equity, an award program in partnership with Kaiser Permanente, by June 30 at 11:59 pm CT. The Award, named in honor…

Read More

By: Judy Mathias
May 19, 2022
Share

Session: Financial implications of unprofessional behavior in the OR

Editor's Note In this presentation, Lynn Webb, PhD, assistant dean for faculty development and assistant professor of Medical Education and Administration at Vanderbilt University Medical Center, made a compelling argument for how unprofessional behavior on the part of clinical staff—including OR personnel—has a direct impact on the financial performance of…

Read More

By: Tarsilla Moura
May 18, 2022
Share

Omicron BA.2.12.1 subvariant gaining a foothold

Editor's Note Though new COVID-19 cases linked to the Omicron BA.2 subvariant are dropping, Omicron’s more infectious subvariant BA2.12.1 is beginning to gain a foothold in the US, the May 10 Becker’s Hospital Review reports. Omicron BA2.12.1 now accounts for nearly 43% of new cases as of May 7, compared…

Read More

By: Judy Mathias
May 11, 2022
Share

FDA: Class I recall of certain Accula SARS-CoV-2 Tests

Editor's Note The Food and Drug Administration (FDA) on May 9 identified the recall by Mesa Biotech, Inc, of certain Accula SARS-CoV-2 Tests as Class I, the most serious. The recall was initiated because certain lots of the PCR test have an increased risk of giving false positive results because…

Read More

By: Judy Mathias
May 11, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat